SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072377
Filing Date
2022-11-14
Accepted
2022-11-14 17:02:53
Documents
44
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_larkspur.htm   iXBRL 10-Q 533516
2 CERTIFICATION f10q0922ex31-1_larkspur.htm EX-31.1 11303
3 CERTIFICATION f10q0922ex31-2_larkspur.htm EX-31.2 11427
4 CERTIFICATION f10q0922ex32-1_larkspur.htm EX-32.1 4472
5 CERTIFICATION f10q0922ex32-2_larkspur.htm EX-32.2 4310
  Complete submission text file 0001213900-22-072377.txt   2920999

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lhac-20220930.xsd EX-101.SCH 37045
7 XBRL CALCULATION FILE lhac-20220930_cal.xml EX-101.CAL 18966
8 XBRL DEFINITION FILE lhac-20220930_def.xml EX-101.DEF 162581
9 XBRL LABEL FILE lhac-20220930_lab.xml EX-101.LAB 298778
10 XBRL PRESENTATION FILE lhac-20220930_pre.xml EX-101.PRE 168769
38 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_larkspur_htm.xml XML 268664
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
Larkspur Health Acquisition Corp. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41184 | Film No.: 221387282
SIC: 2834 Pharmaceutical Preparations